Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

42.9%

3 terminated/withdrawn out of 7 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

167%

5 of 3 completed trials have results

Key Signals

5 with results

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 1

1(16.7%)

6Total

N/A(5)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT01565317Not ApplicableCompleted

Evaluating the Effect of Diabetes Control Through Intensive Lifestyle Modifications on Diabetic Peripheral Neuropathy

Role: collaborator

NCT04680533Phase 1Terminated

Wireless TENS for Peripheral Edema (Lower Limb Swelling)

Role: collaborator

NCT05540002Not ApplicableCompleted

Efficacy of the Quell Wearable Device for Chronic Overlapping Pain Conditions

Role: collaborator

NCT06324344Not ApplicableTerminated

Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy Induced Peripheral Neuropathy (CIPN)

Role: collaborator

NCT05200858Not ApplicableCompleted

Transcutaneous Electrical Nerve Stimulation (TENS) in Patients With Postacute Sequelae of Sars-CoV-2

Role: collaborator

NCT02809846Not ApplicableTerminated

Quell Opioid Reduction and Pain Relief in Patients With Cancer

Role: collaborator

NCT01208545Unknown

Serial Electrophysiologic Monitoring During Administration of Nerve-Toxic Chemotherapeutic Drugs

Role: lead

All 7 trials loaded